0001209191-20-029186.txt : 20200514
0001209191-20-029186.hdr.sgml : 20200514
20200514161924
ACCESSION NUMBER: 0001209191-20-029186
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200512
FILED AS OF DATE: 20200514
DATE AS OF CHANGE: 20200514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEIDEN JEFFREY M
CENTRAL INDEX KEY: 0001242825
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20878063
MAIL ADDRESS:
STREET 1: 40 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-12
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001242825
LEIDEN JEFFREY M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
1
0
0
Executive Chairman
Common Stock
2020-05-12
4
M
0
24215
187.53
A
65036
D
Common Stock
2020-05-12
4
M
0
35499
96.87
A
100535
D
Common Stock
2020-05-12
4
M
0
4470
91.05
A
105005
D
Common Stock
2020-05-12
4
M
0
24348
155.57
A
129353
D
Common Stock
2020-05-12
4
S
0
9015
277.14
D
120338
D
Common Stock
2020-05-12
4
S
0
4428
277.94
D
115910
D
Common Stock
2020-05-12
4
S
0
1940
278.96
D
113970
D
Common Stock
2020-05-12
4
S
0
6498
280.76
D
107472
D
Common Stock
2020-05-12
4
S
0
9398
281.83
D
98074
D
Common Stock
2020-05-12
4
S
0
9780
282.66
D
88294
D
Common Stock
2020-05-12
4
S
0
9219
283.86
D
79075
D
Common Stock
2020-05-12
4
S
0
10179
285.06
D
68896
D
Common Stock
2020-05-12
4
S
0
8391
285.68
D
60505
D
Common Stock
2020-05-12
4
S
0
15792
286.70
D
44713
D
Common Stock
2020-05-12
4
S
0
9630
287.81
D
35083
D
Common Stock
2020-05-12
4
S
0
100
288.42
D
34983
D
Common Stock
440
I
401(k)
Stock Option (Right to Buy)
187.53
2020-05-12
4
M
0
24215
0.00
D
2029-02-05
Common Stock
24215
0
D
Stock Option (Right to Buy)
96.87
2020-05-12
4
M
0
35499
0.00
D
2024-07-14
Common Stock
35499
0
D
Stock Option (Right to Buy)
91.05
2020-05-12
4
M
0
4470
0.00
D
2026-02-01
Common Stock
4470
93866
D
Stock Option (Right to Buy)
155.57
2020-05-12
4
M
0
24348
0.00
D
2028-02-05
Common Stock
24348
0
D
Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $277.14 (range $276.63 to $277.61).
Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $277.94 (range $277.63 to $278.41).
Open market sales reported on this line occurred at a weighted average price of $278.96 (range $278.71 to $279.10).
Open market sales reported on this line occurred at a weighted average price of $280.76 (range $280.17 to $281.13).
Open market sales reported on this line occurred at a weighted average price of $281.83 (range $281.29 to $282.24).
Open market sales reported on this line occurred at a weighted average price of $282.66 (range $282.33 to $283.28).
Open market sales reported on this line occurred at a weighted average price of $283.86 (range $283.35 to $284.30).
Open market sales reported on this line occurred at a weighted average price of $285.06 (range $284.36 to $285.35).
Open market sales reported on this line occurred at a weighted average price of $285.68 (range $285.36 to $286.35).
Open market sales reported on this line occurred at a weighted average price of $286.70 (range $286.37 to $287.31).
Open market sales reported on this line occurred at a weighted average price of $287.81 (range $287.37 to $288.27).
Fully vested.
/s/ Sabrina Yohai, Attorney-in-Fact
2020-05-14